Friday, July 10, 2026

pharma · Interstitial Lung Disease (ILD) · Gastrointestinal Disease

ZhongShan Hospital, Fudan

ZhongShan Hospital, Fudan trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
1936 Founded
624 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1936
Employees
624
Programs
3
Drugs
8
Patents
0
Intelligence · Clinical Trials

ZhongShan Hospital, Fudan clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to ZhongShan Hospital, Fudan programs — each row shows trial ID, program name, phase, status, and indication.

ZhongShan Hospital, Fudan trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for ZhongShan Hospital, Fudan.

  1. ACE001-RI001 — Phase 1

    Clinical update
  2. Norepinephrine — Unknown

    Clinical update
  3. Tocilizumab — Approved

    Clinical update

Trial registry

3 studies